Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Prof Simmons from MRC HIU for this distinction, which recognises her contribution to the fields of innate immunity and inflammatory bowel disease.

We are delighted to announce that Alison Simmons, Professor of Gastroenterology at the Nuffield Department of Medicine and MRC Human Immunology Unit, has been elected a Fellow of the Academy of Medical Sciences.

This honour recognizes her work on innate immunity and inflammatory bowel disease (IBD), a condition where immune dysregulation within the intestine leads to debilitating symptoms and morbidity. Around 40% IBD patients fail to respond to available treatments and while many attempts have been made to introduce new therapies these have failed, as little is understood about the molecular aetiology of intestinal inflammation in human tissue. Her work has provided the rationale for innovative treatments and diagnostic tools.

Research by Prof Simmons and her group has provided fundamental new insights into IBD pathogenesis. Recent work redefined the cellular map of the intestine, discovering unexpected heterogeneity and hitherto unknown cell types. It charted the basis of mucosal remodelling that fuels inflammation in colitis, defining populations of disease associated cells and highlighting new pathways impairing mucosal healing. In other recent work they also defined new molecular determinants of colonic barrier health that break down in colitis to facilitate the cycle of dysbiosis that fuels inflammation.

Previously Prof Simmons also contributed to defining the function of the strongest IBD susceptibility genes, describing the basis for their dysfunction in Crohn’s disease. The group also increased our understanding of pattern recognition receptor biology and immune evasion. This includes how invasive strains of Salmonella cause disseminated disease in immunosuppressed individuals and mechanisms employed by HIV-1 to avoid innate sensing and cell intrinsic immune destruction.

Prof Simmons trained in medicine and gastroenterology in London, Cambridge and Oxford and undertook a PhD with Andrew McMichael in Oxford. She became an NIHR Research Professor in 2013 and Prof of Gastroenterology in 2014, both in Oxford. She is currently a Group Leader in the MRC Human Immunology Unit, Wellcome Investigator and consultant gastroenterologist at OUH NHS FT.

The new 50 Academy of Medical Sciences Fellows have been selected for their outstanding contributions to advancing medical science, cutting edge research discoveries, and translating developments into benefits for patients and wider society. Many of the new Fellows have also made a contribution to medical science through outstanding leadership, public engagement and supporting the career advancement of junior trainees. More information about the new fellows can be found here.

 

Similar stories

Beyond Boundaries at the Oxford Imaging Symposium

Held on 29th September 2022, the symposium brought together researchers from across the world to present the latest applications of advanced imaging.

Anjali Kusumbe receives the RMS Life Sciences Medal

The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.

Learn about cutting-edge research at Oxford Open Doors 2022

On Saturday 10th September 2022 12.30-4 pm, the MRC WIMM will be joining colleagues from the Medical Sciences Division at the Old Road Campus Research Building (ORCRB) as part of the Oxford Open Doors programme. This event is open to everyone.

Fundraising for award in memory of Dr Ling Felce

The Ling Felce award will promote cross-disciplinary excellence in bioinformatics.

Study of T-cell receptor activation leads to surprising discovery

A study from Davis Group is the first to describe the structure of the T-cell receptor when bound to an activating ligand. The findings shed light on an important trigger in the immune system, and suggest a completely new process by which cell receptors can be activated.

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Prof. Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.